AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2947734
Drug: Thiethylperazine (6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiethylperazine (6.5 mg p.o. every 8 h for 5 days)
Trial: 2947734
Drug: Thiethylperazine (6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiethylperazine (6.5 mg p.o. every 8 h for 5 days) plus amitriptyline (25 mg p.o. every 8 h for 5 days)
Trial: 29705442
Drug: Cranberry capsule
DrugBank: Cranberry (DB10631)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry capsule
Trial: 24509962
Drug: Sample group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sample group (received a demonstration on how to apply the medication using a product sample)
Trial: 12575974
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg verapamil
Trial: 9819291
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) at high dose (800 micrograms twice daily)
Trial: 9819291
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAA) at high dose (800 micrograms twice daily)
Trial: 7641720
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia with propofol (Group II)
Trial: 7641720
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol supplemented with nitrous oxide (Group III)
Trial: 2475699
Drug: Falipamil 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Falipamil 100 mg
Trial: 2475699
Drug: Falipamil 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Falipamil 200 mg
Trial: 1093666
Drug: Crossover treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crossover treatment (Adriamycin to 5-fluorouracil and cyclophosphamide)
Trial: 31174929
Drug: Mindful Awareness
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mindful Awareness in Body‐oriented Therapy (MABT)
Trial: 26579797
Drug: Low-sodium wheat
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium wheat bread rich in potassium, GABA, and ACEI peptides (LSB+G)
Trial: 24280478
Drug: Group music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group music therapy (60-min sessions, twice a week for a total of ten sessions)
Trial: 24280478
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (no music therapy)
Trial: 21787474
Drug: Xuebijing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuebijing treatment group (n=39, received bundle treatment + Xuebijing treatment)
Trial: 21787474
Drug: Routine group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine group (n=25, received routine bundle treatment)
Trial: 19420392
Drug: School-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based intervention promoting physical activity and healthy eating; details on dosage and duration not specified
Trial: 17014519
Drug: Threshold levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Threshold levels recommended by NKF for parathyroid hormone
Trial: 10694140
Drug: Low Volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Volume Taper (LVT)
Trial: 10694140
Drug: Moderate Volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate Volume Taper (MVT)
Trial: 10694140
Drug: Taper LICT
RxNorm normalized name: caper berry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taper LICT
Trial: 10694140
Drug: Taper HIIT
RxNorm normalized name: caper berry extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taper HIIT
Trial: 26451734
Drug: Umeclidinium (UMEC;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umeclidinium (UMEC; 62.5 g and 125 g) added to Fluticasone Propionate/Salmeterol (FP/SAL; 250/50 g)
Trial: 26451734
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) added to Fluticasone Propionate/Salmeterol (FP/SAL; 250/50 g)
Trial: 24378514
Drug: Ritonavir-boosted lopinavir
RxNorm normalized name: lopinavir / ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted lopinavir (LPV/r) monotherapy
Trial: 20438516
Drug: Conventional, lactate-buffered,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional, lactate-buffered, acidic solution (solution D)
Trial: 20438516
Drug: Novel, bicarbonate/lactate-buffered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel, bicarbonate/lactate-buffered neutral solution (solution P)
Trial: 10575158
Drug: Adapalene cream
RxNorm normalized name: Adapalene
DrugBank: Adapalene (DB00210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapalene cream and gel
Trial: 10575158
Drug: Tretinoin creams
RxNorm normalized name: Tretinoin
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin creams and gels
Trial: 8951962
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (1.5 micrograms/kg per spray)
Trial: 6310983
Drug: Peripheral parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral parenteral nutrition (PPN) plus enteral nutrition
Trial: 24559194
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate (PP), mean dose/month 70.3 mg eq. (109.6 mg), median duration of exposure 204 days.
Trial: 21173515
Drug: Bucolome combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucolome combination therapy (BC) - bucolome 300 mg/day
Trial: 21173515
Drug: Warfarin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin monotherapy (WM)
Trial: 15741469
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral social skills training (combined treatment)
Trial: 9704181
Drug: Dermofilm (topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermofilm (topical preparation)
Trial: 7818622
Drug: Acadesine high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acadesine high-dose infusion
Trial: 7818622
Drug: Acadesine low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Acadesine low-dose infusion
Trial: 2698947
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg twice a day for 2 weeks; 40 mg twice a day for 6 weeks)
Trial: 31796521
Drug: Tisotumab vedotin
RxNorm normalized name: Tisotumab vedotin
DrugBank: Tisotumab vedotin (DB16732)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tisotumab vedotin 2.0 mg/kg every 3 weeks until progressive disease, unacceptable toxicity, or consent withdrawal
Trial: 24596005
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol valerate and 2 mg dienogest
Trial: 24596005
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol valerate and 10 mg medroxyprogesterone acetate
Trial: 12100094
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg rizatriptan plus 25 mg rofecoxib
Trial: 7553242
Drug: Oxymetazoline nasal
RxNorm normalized name: oxymetazoline nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetazoline nasal spray with benzalkonium chloride
Trial: 10522506
Drug: Oxymetazoline nasal
RxNorm normalized name: oxymetazoline nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetazoline nasal spray without benzalkonium chloride
Trial: 7008367
Drug: Silymarin treatment
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin treatment
Trial: 31701699
Drug: γ-linolenic acid
RxNorm normalized name: γ-linolenic acid
DrugBank: Gamolenic acid (DB13854)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ-linolenic acid (GLA) 320 mg/day
Trial: 31701699
Drug: α-lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-lipoic acid (ALA) 600 mg/day
Trial: 25748566
Drug: Nebulized pentoxifylline
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized pentoxifylline (20 mg/kg every 6 hours for 10 days)
Trial: 22321931
Drug: FICB with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FICB with ropivacaine 0.2%, 1 ml/kg, max. 30 ml
Trial: 22321931
Drug: FICB with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FICB with 0.9% normal saline 1 ml/kg, max. 30 ml
Trial: 19390463
Drug: Intravaginal estriol
RxNorm normalized name: Estriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal estriol (1 mg) and progesterone (30 mg) suppositories
Trial: 2383027
Drug: Intralesional sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional sustained release interferon alfa‐2b (10 million IU per injection) - 3 injections
Trial: 2383027
Drug: Intralesional sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional sustained release interferon alfa‐2b (10 million IU per injection) - 1 injection
Trial: 31163231
Drug: FMX101 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FMX101 4% topical minocycline foam
Trial: 28160190
Drug: CKD-712 160
RxNorm normalized name: CKD-504
DrugBank: CKD-504 (DB18235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CKD-712 160 µg/kg
Trial: 28160190
Drug: CKD-712 320
RxNorm normalized name: CKD-504
DrugBank: CKD-504 (DB18235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CKD-712 320 µg/kg
Trial: 28160190
Drug: CKD-712 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CKD-712 (20 to 240 µg/kg)
Trial: 22842478
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of cyclophosphamide
Trial: 20732868
Drug: Relaxin (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxin (four doses)
Trial: 16690006
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose venlafaxine (75 mg/d)
Trial: 16690006
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose venlafaxine (up to 375 mg/d)
Trial: 16690006
Drug: Both low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both low and high doses of venlafaxine
Trial: 16225720
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with midazolam 0.1 mg kg(‐1) (Group PM)
Trial: 31863040
Drug: Recommendation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommendation of root canal treatment for White patients (86.21%)
Trial: 28862883
Drug: VR-CHOP (R-CHOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VR-CHOP (R-CHOP + bortezomib 1.3 mg/m2 on days 1 and 4)
Trial: 24444988
Drug: 0.5 mg/kg/hr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg/hr of ketamine and 2 mg/kg/hr of propofol
Trial: 23646099
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg LD-¹³C with randomized CD doses (0, 25, 50, 100 and 200 mg)
Trial: 23646099
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg LD-¹³C with increasing CD doses
Trial: 23646099
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg LD-¹³C
Trial: 19356374
Drug: Oxymetholone 50
RxNorm normalized name: oxymetholone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetholone 50 mg orally twice daily for 24 weeks
Trial: 19356374
Drug: Placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo twice daily for 24 weeks
Trial: 18080043
Drug: Pulsed electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed electromagnetic field (PEMF) treatment (400 microT), twice-daily 40 min treatments over seven days
Trial: 16805716
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy (high doses)
Trial: 16805716
Drug: Less intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intensive statin therapy
Trial: 15242434
Drug: Double injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double injection of 15 ml of 0.75% ropivacaine to each sciatic nerve component (total 30 ml)
Trial: 15242434
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of 30 ml of 0.75% ropivacaine to the sciatic nerve
Trial: 10866909
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection
Trial: 8620641
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (primary repair plus early controlled mobilization)
Trial: 8620641
Drug: Functional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional treatment (early controlled mobilization alone)
Trial: 12602423
Drug: Cognitive‐behavioral therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral therapy (CBT)
Trial: 26594944
Drug: Cognitive‐behavioral therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral therapy (CBT) and Interpersonal psychotherapy (IPT)
Trial: 19577636
Drug: Subvirion avian
RxNorm normalized name: Asian ginseng extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subvirion avian influenza A/H5N1 vaccine with aluminum hydroxide (AlOH)
Trial: 19577636
Drug: Subvirion avian
RxNorm normalized name: Asian ginseng extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subvirion avian influenza A/H5N1 vaccine without aluminum hydroxide (AlOH)
Trial: 19577636
Drug: Subvirion avian
RxNorm normalized name: Asian ginseng extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subvirion avian influenza A/H5N1 vaccine (all doses)
Trial: 19577636
Drug: Subvirion avian
RxNorm normalized name: Asian ginseng extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subvirion avian influenza A/H5N1 vaccine (45microg HA)
Trial: 19577636
Drug: Subvirion avian
RxNorm normalized name: Asian ginseng extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subvirion avian influenza A/H5N1 vaccine (45microg HA with AlOH)
Trial: 15204280
Drug: Upward loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upward loading with different load magnitudes (250, 750, and 1250 g) during five- and three-digit grasps.
Trial: 15204280
Drug: Downward loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Downward loading with different load magnitudes (250, 750, and 1250 g) during five- and three-digit grasps.
Trial: 11579363
Drug: Carvedilol monotherapy
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol monotherapy
Trial: 11579363
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Captopril + Carvedilol)
Trial: 9795022
Drug: Rectal suppository
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal suppository
Trial: 7986489
Drug: D-cycloserine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine (25 to 500 mg daily, dose escalation phase)
Trial: 2929903
Drug: Lignocaine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 1.5 mg/kg
Trial: 26905703
Drug: Lignocaine 2
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 2 mg/kg
Trial: 27943397
Drug: Thiopurine treatment
RxNorm normalized name: thiotaurine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopurine treatment with 6-MMP concentrations measured at T1 (1 week after treatment initiation)
Trial: 24089534
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of NT-proBNP and hs-cTnT
Trial: 21122848
Drug: 600‐μg oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600‐μg oral misoprostol
Trial: 8588792
Drug: dimenhydrinate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dimenhydrinate (100 mg)
Trial: 15468399
Drug: Topical negative
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical negative pressure dressing
Trial: 11854606
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 500 mg b.i.d. for a mean of 12.5 weeks
Trial: 10510161
Drug: Digoxin alone
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin alone (0.5 mg)
Trial: 10510161
Drug: Digoxin with
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin with macrogol 4000 (20 g day-1 for 8 days)
Trial: 7737960
Drug: Adinazolam-SR 60
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam-SR 60 mg/day
Trial: 7737960
Drug: Adinazolam-SR 90
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam-SR 90 mg/day
Trial: 7737960
Drug: Adinazolam-SR 30
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam-SR 30 mg/day
Trial: 2439814
Drug: bopindolol 1
RxNorm normalized name: bopindolol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol 1 mg
Trial: 30853250
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (50 mg/kg once daily) at home
Trial: 30853250
Drug: Intravenous flucloxacillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous flucloxacillin (50 mg/kg every 6 h) in hospital
Trial: 28395998
Drug: Collagenase Clostridium
RxNorm normalized name: Collagenase Clostridium Histolyticum
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase Clostridium histolyticum (CCH) intralesional injection (0.58 mg/injection, up to eight injections)
Trial: 28395998
Drug: CCH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCH treatment of male partners
Trial: 24946799
Drug: Robot-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robot-assisted therapy (30 sessions)
Trial: 24946799
Drug: Usual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual physical therapy (30 sessions)
Trial: 23002124
Drug: PEG‐IFN (peginterferon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐IFN (peginterferon alfa‐2b), 6 μg/kg per week for eight doses, followed by 3 μg/kg per week for up to 252 weeks
Trial: 19735181
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g n-3 PUFAs
Trial: 19735181
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g n-3 PUFAs
Trial: 9007484
Drug: Tetanus-PRP conjugate
RxNorm normalized name: HEMOPHILUS B CONJUGATE(TETANUS TOXOID CONJUGATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus-PRP conjugate vaccine
Trial: 8393606
Drug: 10(4) p.f.u.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(4) p.f.u. dose of rhesus rotavirus serotype 3
Trial: 8393606
Drug: 10(5) p.f.u.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(5) p.f.u. dose of rhesus rotavirus serotype 3
Trial: 8393606
Drug: 10(4) p.f.u.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(4) p.f.u. dose of tetravalent rotavirus vaccine
Trial: 8393606
Drug: 10(5) p.f.u.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(5) p.f.u. dose of tetravalent rotavirus vaccine
Trial: 8393606
Drug: Grouped vaccines
RxNorm normalized name: meningococcal group B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grouped vaccines at 10(5) p.f.u. (single serotype and tetravalent)
Trial: 3578925
Drug: Intranasal IgE
RxNorm normalized name: IG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal IgE pentapeptide 0.5%
Trial: 27619403
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg omega-3 fatty acids from flaxseed oil containing 400 mg α-Linolenic acid plus 400 IU vitamin E supplements (n = 34)
Trial: 27619403
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg omega-3 fatty acids and vitamin E co-supplementation
Trial: 17264186
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone treatment (1 mg/m2.d)